expressbpdOctober 10, 2017
Tag: Marksans Pharma , Goa facility , EIR
EIR is issued to a company detailing inspectional findings
Marksans Pharma has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility.
The company has received EIR from the United States Food and Drug Administration (USFDA) after inspection of its Goa facility from April 3-7, 2017, Marksans Pharma said in a BSE filing.
As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: